Proteomics International Laboratories Ltd (ASX:PIQ) US Medicare Confirms Reimbursement Price for PromarkerD

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the US Centers for Medicare & Medicaid Services has published its final determination of the national reimbursement price in the United States for the PromarkerD predictive test for diabetic kidney disease.

Related Keywords

United States ,Perth ,Western Australia ,Australia ,Americans ,American ,Richard Lipscombe ,Proteomics International Laboratories Ltd ,Proteomics International ,American Medical Association ,Proteomics International Laboratories ,Us Centers For Medicare Medicaid Services ,Cptr Proprietary Laboratory Analyses ,Medicare Advisory Panel On Clinical Diagnostic Laboratory ,Confirms Reimbursement Price ,International Laboratories Ltd ,Medicaid Services ,Sonic Healthcare United States ,Medicare Advisory Panel ,Clinical Diagnostic Laboratory Tests ,Proprietary Laboratory Analyses ,International Laboratories ,Biotech ,Health Pharm Generalproteomics International Laboratories Ltd ,Asx Piq ,